SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600132-17-000100
Filing Date
2017-09-26
Accepted
2017-09-26 16:54:01
Documents
1
Period of Report
2017-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_150645922823895.html 4  
1 FORM 4 wf-form4_150645922823895.xml 4 3905
  Complete submission text file 0001600132-17-000100.txt   5369
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Peacock Jonathan M (Reporting) CIK: 0001500241 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 171102579

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations